http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115124468-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_215fd62f148bc5aab2bfc8e46ecd6126
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-584
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D201-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D201-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-10
filingDate 2022-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7d1349f1cb0a8fe0f69906cea429984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_312f0519576b7a7ac6aca7b5edcc8b27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3b4920b7d63d3019fddaab896312ea3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ab885da6b9df4a29c698f6d9d29fac9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cecf80bc101de58accd9efab95fb4942
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7108217df578754d69699205aa17d2a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52a0b7577b820b68f56be6b70750bb58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f072792c91dd139d8932b21602de5a0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3c5e7a840fe6d752888adbaf5e3c17e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec19e591bdc0c97b6c11a17b636c6f24
publicationDate 2022-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-115124468-A
titleOfInvention A kind of method for preparing caprolactam
abstract A method for preparing caprolactam, which is characterized in that in a two-phase reaction system composed of a B-L biacid deep eutectic solvent and an organic solvent, cyclohexanone oxime is used as a raw material to prepare caprolactam through rearrangement reaction, a deep eutectic solvent and a cyclic The molar ratio of hexanone oxime is 25:1 to 1:25, the organic solvent is 1 to 30 mL, and the reaction temperature is 40 to 120° C. for 2 to 8 hours to prepare caprolactam, and the deep eutectic solvent and the organic solvent are recovered and reused. The characteristics of the present invention are: the deep eutectic solvent-organic solvent two-phase system can realize high-yield and high-purity synthesis of caprolactam; the solubility difference between the deep eutectic solvent and the organic solvent for reactants and products is well avoided. The hydrolysis of the cyclohexanone oxime inhibits side reactions such as the oligomerization of the product caprolactam; the reaction conditions are mild, the product is easy to separate, the processing is simple, and the used deep eutectic solvent and organic solvent are easy to recover and reusable.
priorityDate 2022-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449957047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453739895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452183629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID236409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452641922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449360014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6421
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6422
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21663959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415893423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007855

Total number of triples: 65.